International Journal of Hematology

DOI: 10.1007/s12185-019-02663-5 Pages: 125-126

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study)

1. Gunma University Graduate School of Health Sciences, Department of Laboratory Sciences

2. Toyama University Hospital, Department of Hematology

3. Chugoku Central Hospital, Department of Hematology

4. Nagoya University Hospital, Department of Clinical Laboratory

5. Nagasaki Prefectural Shimabara Hospital, Department of Hematology

6. Kanazawa University Hospital, Department of Hematology

7. Gunma University, Department of Hematology

8. Tokushima Prefectural Central Hospital, Department of Hematology

9. Tokushima University Hospital, Division of Transfusion Medicine and Cell Therapy

10. Gifu Municipal Hospital, Department of Hematology

11. Yokkaichi Municipal Hospital, Department of Hematology

12. Toki Municipal General Hospital, Department of Hematology

13. Japanese Red Cross Nagoya Daiichi Hospital, Department of Hematology

14. Ogaki Municipal Hospital, Department of Hematology

15. Higashi Nagoya National Hospital, Department of Hematology/Oncology

Correspondence to:
Hirokazu Murakami
Tel: +81-27-220-8973
Email: hmura@gunma-u.ac.jp

Close

Abstract

The authors would like to correct the errors in the publication of the original article. The correction details are given below.

This article is freely available, click here to access the full text/PDF

Share the Knowledge